SOCS3 and Alzheimer disease: To study whether the JAK2-STAT3 pathway controls astrocyte reactivity in AD, we inhibited this pathway by overexpressing its endogenous inhibitor Suppressor Of Cytokine Signaling 3 (SOCS3, [6]) in APP/PS1dE9 mice (hereafter called APP mice).